Literature DB >> 17082760

Association study between the CX3CR1 gene and asthma.

K Tremblay1, M Lemire, V Provost, T Pastinen, Y Renaud, A J Sandford, M Laviolette, T J Hudson, C Laprise.   

Abstract

CX3CR1, a fractalkine receptor, mediates cell-adhesive and migratory functions in inflammation. Based on CX3CR1 expression observed in bronchial tissues of asthmatic subjects, we hypothesized that genetic variation at this locus may affect susceptibility to asthma. We carried out an association study and a haplotypic analysis with selected polymorphisms of the CX3CR1 in a familial asthmatic sample from a founder population. Genetic analyses performed by FBAT software showed five CX3CR1 single nucleotide polymorphisms (rs938203, rs2669849, rs1050592, T280M and V249I) with significant associations between their common alleles and asthma (P<0.004) in a dominant model. A haplotype formed with common alleles of rs1050592, T280M and V249I is also overtransmitted in asthmatic subjects (P=0.005) under a dominant model. The associations of V249I and rs2669849 have been validated in an independent case-control sample. For V249I, odds ratios (OR) are 2.16 (common homozygous) and 2.11 (heterozygous) in dominant model (P=0.031). For rs2669849, OR are 2.75 (common homozygous) and 1.86 (heterozygous) in additive model (P=0.007) and dominant model (P=0.059). These results suggest an asthma protective effect of the minor alleles in healthy control carriers. Further functional studies of CX3CR1 are needed to document its role in the pathophysiology of asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082760     DOI: 10.1038/sj.gene.6364340

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  17 in total

1.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung.

Authors:  Cyrille Mionnet; Vanessa Buatois; Akira Kanda; Valerie Milcent; Sebastien Fleury; David Lair; Marie Langelot; Yannick Lacoeuille; Edith Hessel; Robert Coffman; Antoine Magnan; David Dombrowicz; Nicolas Glaichenhaus; Valerie Julia
Journal:  Nat Med       Date:  2010-10-31       Impact factor: 53.440

2.  Analyses of associations with asthma in four asthma population samples from Canada and Australia.

Authors:  Denise Daley; Mathieu Lemire; Loubna Akhabir; Moira Chan-Yeung; Jian Qing He; Treena McDonald; Andrew Sandford; Dorota Stefanowicz; Ben Tripp; David Zamar; Yohan Bosse; Vincent Ferretti; Alexandre Montpetit; Marie-Catherine Tessier; Allan Becker; Anita L Kozyrskyj; John Beilby; Pamela A McCaskie; Bill Musk; Nicole Warrington; Alan James; Catherine Laprise; Lyle J Palmer; Peter D Paré; Thomas J Hudson
Journal:  Hum Genet       Date:  2009-02-27       Impact factor: 4.132

3.  Decreased response to inhaled steroids in overweight and obese asthmatic children.

Authors:  Erick Forno; Rachel Lescher; Robert Strunk; Scott Weiss; Anne Fuhlbrigge; Juan C Celedón
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

Review 4.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

5.  Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.

Authors:  Debra A Schaumberg; Lynda Rose; Margaret M DeAngelis; Richard D Semba; Gregory S Hageman; Daniel I Chasman
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

6.  Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.

Authors:  Amalia Enríquez-de-Salamanca; Evangelina Castellanos; Michael E Stern; Itziar Fernández; Ester Carreño; Carmen García-Vázquez; Jose M Herreras; Margarita Calonge
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

7.  Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

Authors:  Shekar Srinivas; Jihong Dai; Joyce Eskdale; Grant E Gallagher; Nicholas J Megjugorac; Grant Gallagher
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

8.  Fractalkine receptor polymorphism and chronic tonsillitis.

Authors:  Seda Turkoglu Babakurban; Selim S Erbek; Yunus Kasim Terzi; Fatih Arslan; Feride I Sahin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-05       Impact factor: 2.503

9.  Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.

Authors:  K Klosowska; M V Volin; N Huynh; K K Chong; M M Halloran; J M Woods
Journal:  Clin Exp Immunol       Date:  2009-03-11       Impact factor: 4.330

10.  High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1.

Authors:  Hui Ren; Daoyong Yu; Baosheng Ge; Brian Cook; Zhinan Xu; Shuguang Zhang
Journal:  PLoS One       Date:  2009-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.